10/14/2026
Ibogaine's potential in addiction treatment faces cardiac risks
New review highlights ibogaine's promise and dangers in addiction therapy.
Topic archive
substance use disorders
10 stories
10/8/2026
Texas ibogaine trials face funding gap as federal support looms
Federal funds may replace private investment in Texas ibogaine research
10/2/2026
Ibogaine draws Americans to Mexico for costly psychedelic retreats
High-profile figures seek ibogaine for personal growth, despite U.S. restrictions.
9/23/2026
NeuroThera expands U.S. patents for psychedelic therapies
New patents cover LSD, ketamine, ibogaine combinations for mental health.
9/23/2026
Clearmind expands U.S. patent portfolio with new applications
Patent applications cover novel combinations of LSD, ketamine, and ibogaine.
9/23/2026
NeuroThera expands U.S. patent portfolio with ibogaine
Collaboration with Clearmind Medicine enhances therapeutic potential for mental health and substance use disorders.
9/23/2026
NeuroThera expands U.S. patent portfolio with Clearmind
New patent applications cover LSD, ketamine, and ibogaine combinations for mental health.
9/22/2026
Presley Gerber's ibogaine treatment journey before his death
Model Presley Gerber sought ibogaine therapy in Mexico amid addiction struggles.
8/12/2026
UC Irvine explores ibogaine's impact on the brain
NBC San Diego reports on UC Irvine's ibogaine research and patient recovery.
7/16/2026
Texas leaders advocate for ibogaine research
Veterans share recovery stories, highlighting ibogaine's potential.